Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases
Authors
Keywords
Lipoxins, Resolution of inflammation, Renal inflammation, Fibrosis, AT-01-KG, Cellular plasticity
Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
Volume 1866, Issue 8, Pages 158940
Publisher
Elsevier BV
Online
2021-04-09
DOI
10.1016/j.bbalip.2021.158940
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis of ligand binding modes at the human formyl peptide receptor 2
- (2020) Tong Chen et al. Nature Communications
- A novel role for lipoxin A4 in driving a lymph node-eye axis that controls autoimmunity to the neuroretina
- (2020) Jessica Wei et al. eLife
- Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
- (2020) James F. Markworth et al. JCI Insight
- Kidney Single-Cell Atlas Reveals Myeloid Heterogeneity in Progression and Regression of Kidney Disease
- (2020) Bryan R. Conway et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- LXA4-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-β/Smad signaling
- (2020) Hyunjung Kim et al. Cell Death & Disease
- Is Resolution the End of Inflammation?
- (2019) Karen T. Feehan et al. TRENDS IN MOLECULAR MEDICINE
- Macrophages: versatile players in renal inflammation and fibrosis
- (2019) Patrick Ming-Kuen Tang et al. Nature Reviews Nephrology
- Leukocytes from obese individuals exhibit an impaired SPM signature
- (2019) Cristina López-Vicario et al. FASEB JOURNAL
- Lipid mediators in immune regulation and resolution
- (2019) Derek W. Gilroy et al. BRITISH JOURNAL OF PHARMACOLOGY
- A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
- (2019) Monika A. Niewczas et al. NATURE MEDICINE
- Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines
- (2019) Yihua Bai et al. MEDICAL SCIENCE MONITOR
- Specialized pro-resolving mediators in diabetes: novel therapeutic strategies
- (2019) Eoin P. Brennan et al. CLINICAL SCIENCE
- Specialized pro-resolving lipid mediators are differentially altered in peripheral blood of patients with multiple sclerosis and attenuate monocyte and blood-brain barrier dysfunction
- (2019) Gijs Kooij et al. HAEMATOLOGICA
- Safety profile of autologous macrophage therapy for liver cirrhosis
- (2019) Francesca Moroni et al. NATURE MEDICINE
- Inflammation in Renal Diseases: New and Old Players
- (2019) Vinicius Andrade-Oliveira et al. Frontiers in Pharmacology
- The role of non-resolving inflammation in atherosclerosis
- (2018) Canan Kasikara et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipoxins Regulate the Early Growth Response–1 Network and Reverse Diabetic Kidney Disease
- (2018) Eoin P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Anti-fibrotic treatments: A review of clinical evidence
- (2018) Marco Allinovi et al. MATRIX BIOLOGY
- Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury
- (2018) Elena Lazzeri et al. Nature Communications
- Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2
- (2018) A. Gaudin et al. Scientific Reports
- Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis
- (2018) E. P. Brennan et al. DIABETES
- Asymmetric synthesis and biological evaluation of imidazole- and oxazole-containing synthetic lipoxin A4 mimetics (sLXms)
- (2018) Monica de Gaetano et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Immune resolution mechanisms in inflammatory arthritis
- (2017) Mauro Perretti et al. Nature Reviews Rheumatology
- Low dose aspirin increases 15-epi-lipoxin A4 levels in diabetic chronic kidney disease patients
- (2017) Marian Goicoechea et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Pilot application of lipoxin A4 analog and lipoxin A4 receptor agonist in asthmatic children with acute episodes
- (2017) Xia Kong et al. Experimental and Therapeutic Medicine
- Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice
- (2016) Joana Viola et al. CIRCULATION RESEARCH
- Highly Dynamic Transcriptional Signature of Distinct Macrophage Subsets during Sterile Inflammation, Resolution, and Tissue Repair
- (2016) Tamas Varga et al. JOURNAL OF IMMUNOLOGY
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
- (2016) Gabrielle Fredman et al. Nature Communications
- Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
- (2015) Emma Börgeson et al. Cell Metabolism
- Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps
- (2015) H. Rabb et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins
- (2015) Eleonora Cianci et al. Stem Cells Translational Medicine
- Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population
- (2015) Dan Yu et al. PLoS One
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- Immune system modulation of kidney regeneration—mechanisms and implications
- (2014) Hans-Joachim Anders Nature Reviews Nephrology
- Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation
- (2013) A. Neuhofer et al. DIABETES
- Lipoxin A4modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism
- (2013) Sesquile Ramon et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophage Phenotype Controls Long-Term AKI Outcomes--Kidney Regeneration versus Atrophy
- (2013) M. Lech et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Lipoxins Attenuate Renal Fibrosis by Inducing let-7c and Suppressing TGF R1
- (2013) E. P. Brennan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy and safety of 15(R/S)-methyl-lipoxin A4in topical treatment of infantile eczema
- (2012) S.-H. Wu et al. BRITISH JOURNAL OF DERMATOLOGY
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
- (2012) P. Ramachandran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications
- (2012) Emma Börgeson et al. Frontiers in Immunology
- Lipoxin A4 and benzo-lipoxin A4 attenuate experimental renal fibrosis
- (2011) Emma Börgeson et al. FASEB JOURNAL
- Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis
- (2011) Hans-Joachim Anders et al. KIDNEY INTERNATIONAL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
- (2010) Paola Maderna et al. FASEB JOURNAL
- Macrophage Wnt7b is critical for kidney repair and regeneration
- (2010) S.-L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipoxins: resolutionary road
- (2009) Paola Maderna et al. BRITISH JOURNAL OF PHARMACOLOGY
- Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells
- (2009) N. Baker et al. JOURNAL OF IMMUNOLOGY
- Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury
- (2009) Alaa S. Awad et al. KIDNEY INTERNATIONAL
- Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs
- (2009) Yee-Ping Sun et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Elevated Expressions of 15-Lipoxygenase and Lipoxin A4 in Children with Acute Poststreptococcal Glomerulonephritis
- (2008) Sheng-Hua Wu et al. AMERICAN JOURNAL OF PATHOLOGY
- Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe Asthma
- (2008) Anna Planagumà et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties
- (2008) Nicos A. Petasis et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions
- (2008) Charles N. Serhan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Origin and physiological roles of inflammation
- (2008) Ruslan Medzhitov NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started